These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14624194)

  • 1. Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.
    Kotlyar M; Brewer ER; Golding M; Carson SW
    J Clin Psychopharmacol; 2003 Dec; 23(6):652-6. PubMed ID: 14624194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    DeVane CL; Donovan JL; Liston HL; Markowitz JS; Cheng KT; Risch SC; Willard L
    J Clin Psychopharmacol; 2004 Feb; 24(1):4-10. PubMed ID: 14709940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
    J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nefazodone and cyclosporine drug-drug interaction.
    Wright DH; Lake KD; Bruhn PS; Emery RW
    J Heart Lung Transplant; 1999 Sep; 18(9):913-5. PubMed ID: 10528754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
    Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a fluoxetine effect on prednisolone disposition and cortisol suppression.
    Carson SW; Letrent KJ; Kotlyar M; Foose G; Tancer ME
    Pharmacotherapy; 2004 Apr; 24(4):482-7. PubMed ID: 15098802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.
    Lebrun-Vignes B; Archer VC; Diquet B; Levron JC; Chosidow O; Puech AJ; Warot D
    Br J Clin Pharmacol; 2001 May; 51(5):443-50. PubMed ID: 11422002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD
    J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment: possible interaction between nefazodone and pravastatin.
    Bottorf MB
    Ann Pharmacother; 2000 Apr; 34(4):538, 541. PubMed ID: 10772447
    [No Abstract]   [Full Text] [Related]  

  • 14. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Lam YW; Alfaro CL; Ereshefsky L; Miller M
    J Clin Pharmacol; 2003 Nov; 43(11):1274-82. PubMed ID: 14551182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of nefazodone.
    Greene DS; Barbhaiya RH
    Clin Pharmacokinet; 1997 Oct; 33(4):260-75. PubMed ID: 9342502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nefazodone on clozapine plasma concentrations.
    Taylor D; Bodani M; Hubbeling A; Murray R
    Int Clin Psychopharmacol; 1999 May; 14(3):185-7. PubMed ID: 10435773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
    Salazar DE; Marathe PH; Fulmor IE; Lee JS; Raymond RH; Uderman HD
    J Clin Pharmacol; 1995 Nov; 35(11):1109-18. PubMed ID: 8626885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone.
    Hagan JB; Erickson D; Singh RJ
    Pain Med; 2010 Jul; 11(7):1132-5. PubMed ID: 20456080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.